Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedema

Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedema

Background: Landmark studies reported on faricimab efficacy and safety predominantly in treatment naïve patients, but outcomes following switch from other anti-VEGF therapies are lacking. We evaluated patients switched to faricimab who had previously shown a partial response to other anti-VEGF injec...

書誌詳細
主要な著者:	Borchert, GA, Kiire, CA, Stone, NM, Akil, H, Gkika, T, Fischer, MD, Xue, K, Cehajic-Kapetanovic, J, MacLaren, RE, Charbel Issa, P, Downes, SM, De Silva, SR
フォーマット:	Journal article
言語:	English
出版事項:	Springer Nature [academic journals on nature.com] 2024

類似資料

Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy
著者:: Borchert, GA, 等
出版事項: (2024)

Efficacy, Durability and Safety of Faricimab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Oedema: Lessons Learned from Registration Trials
著者:: Helene O. Larsen, 等
出版事項: (2023-07-01)

Two-wavelength fundus autofluorescence and macular pigment optical density imaging in diabetic macular oedema.
著者:: Waldstein, S, 等
出版事項: (2012)

Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
著者:: Lorenzo Ferro Desideri, 等
出版事項: (2023-05-01)

Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration
著者:: Hang A, 等
出版事項: (2024-12-01)

Intravitreal Faricimab for Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
著者:: Rush RB, 等
出版事項: (2022-12-01)

Real-World Outcomes of Faricimab Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
著者:: Quah NQX, 等
出版事項: (2024-05-01)

Eligibility for faricimab in a real-world diabetic macular oedema population: a cross-sectional study
著者:: Helena Norberg, 等
出版事項: (2025-02-01)

Summary of Research: Cost‑Effectiveness of Faricimab in the Treatment of Diabetic Macular Oedema (DMO): A UK Analysis
著者:: Christian Bührer, 等
出版事項: (2024-06-01)

Outcomes After Switching to Faricimab for Refractive Macular Edema in Treatment-Experienced Eyes with Neovascular Age-Related Macular Degeneration
著者:: Qaseem Y, 等
出版事項: (2024-10-01)

Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy
著者:: Grace A. Borchert, 等
出版事項: (2024-07-01)

Machine Learning to Predict Faricimab Treatment Outcome in Neovascular Age-Related Macular Degeneration
著者:: Yusuke Kikuchi, PhD, 等
出版事項: (2024-03-01)

Diabetic macular oedema: under‐represented in the genetic analysis of diabetic retinopathy
著者:: Broadgate, S, 等
出版事項: (2018)

CDHR1-related late-onset macular dystrophy: further insights
著者:: Yusuf, IH, 等
出版事項: (2020)

Cost-Effectiveness and Budget Impact Analysis of the Use of Faricimab in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration in Colombia
著者:: Daniel Samacá-Samacá, 等
出版事項: (2025-03-01)

Persistent macular oedema following Best vitelliform macular dystrophy undergoing anti-VEGF treatment
著者:: Tie-Zhu Lin, 等
出版事項: (2022-05-01)

Real-World Data on Faricimab Switching in Treatment-Refractory Neovascular Age-Related Macular Degeneration
著者:: Benjamin Ng, 等
出版事項: (2024-01-01)

Retinal and choroidal efficacy of switching treatment to faricimab in recalcitrant neovascular age related macular degeneration
著者:: Franziska Eckardt, 等
出版事項: (2024-04-01)

Initial Real-World Experience with Faricimab in Treatment-Resistant Neovascular Age-Related Macular Degeneration
著者:: Leung EH, 等
出版事項: (2023-05-01)

One-Year Outcomes of Faricimab Treatment for Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
著者:: Rush RB
出版事項: (2023-08-01)

The Role of Inflammation in Age-Related Macular Degeneration—Therapeutic Landscapes in Geographic Atrophy
著者:: Grace A. Borchert, 等
出版事項: (2023-08-01)

Faricimab for Treatment-Resistant Diabetic Macular Edema
著者:: Rush RB, 等
出版事項: (2022-08-01)

Cystoid macular oedema
著者:: Singh Daljit
出版事項: (1983-01-01)

Cystoid macular oedema
著者:: Natarajan Mathivanan, 等
出版事項: (1984-01-01)

Faricimab versus the standard of care for neovascular age-related macular degeneration in Italy: an indirect treatment comparison
著者:: Carlotta Galeone, 等
出版事項: (2024-12-01)

Real-world efficacy of intravitreal faricimab for neovascular age-related macular degeneration: a systematic review
著者:: Nasratullah Nasimi, 等
出版事項: (2024-07-01)

Factors Associated with Success of Switching to Faricimab for Neovascular Age-Related Macular Degeneration Refractory to Intravitreal Aflibercept
著者:: Akira Machida, 等
出版事項: (2024-04-01)

First-Year Real-Life Experience with Intravitreal Faricimab for Refractory Neovascular Age-Related Macular Degeneration
著者:: Wissam Aljundi, 等
出版事項: (2024-03-01)

Real-World Outcomes of a Loading Phase with Intravitreal Faricimab in Neovascular Age-Related Macular Degeneration (n-AMD) and Diabetic Macular Edema (DME)
著者:: Ermete Giancipoli, 等
出版事項: (2024-06-01)

Dynamics of Treatment Response to Faricimab for Diabetic Macular Edema
著者:: Katrin Fasler, 等
出版事項: (2024-09-01)

Efficacy and safety of faricimab for neovascular age-related macular degeneration: a systematic review and network meta-analysis
著者:: Francisco Rodríguez, 等
出版事項: (2024-05-01)

Initial experiences of switching to faricimab for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in an Asian population
著者:: Farah N. I. Ibrahim, 等
出版事項: (2024-01-01)

One-Year Real-World Outcomes of Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration
著者:: Giuseppe Cancian, 等
出版事項: (2024-09-01)

Short-Term Outcomes of 3 Monthly intravitreal Faricimab On Different Subtypes of Neovascular Age-Related Macular Degeneration
著者:: Tanaka A, 等
出版事項: (2024-02-01)

Efficacy and safety of intravitreal faricimab for neovascular age-related macular degeneration: a systematic review and meta-analysis
著者:: Wei-Ting Yen, 等
出版事項: (2024-01-01)

Macular Thickness- An Early Predictor of Diabetic Macular Oedema
著者:: Chandrika Sareddy, 等
出版事項: (2022-05-01)

Gene therapy for age-related macular degeneration
著者:: MacLaren, RE
出版事項: (2015)

The Architecture of Macular Neovascularizations Predicts Treatment Responses to Anti-VEGF Therapy in Neovascular AMD
著者:: Henrik Faatz, 等
出版事項: (2022-11-01)

Evaluating Faricimab in Treatment-Naive Neovascular Age Related Macular Degeneration: A Retrospective Analysis of Real-World Data
著者:: Modeste D, 等
出版事項: (2024-10-01)

Intravitreal faricimab for treatment naïve patients with neovascular age-related macular degeneration: a real-world prospective study
著者:: Gabriela Grimaldi, 等
出版事項: (2024-09-01)